GP Vivas · respiratory-health
Lung cancer suspicion — structured viva
Structured oral on lung cancer suspicion: the normal CXR trap, NLST and NELSON screening evidence, the Brock model for nodule assessment, incidental nodule management, and referral triggers.
On this page
Study tools
Target exams
RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'A smoker has a normal CXR — you can reassure him, right?' The viva branches through the CXR limitation, screening evidence, nodule assessment and referral triggers.
Stem
You are the GP. The colleague trusts a normal CXR completely. [1]
References3ShowHide
- [1]Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med, 2011.PMID 21714641
- [2]de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial N Engl J Med, 2020.PMID 31995683
- [3]Winter A, Aberle DR, Hsu W External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data Thorax, 2019.PMID 30898897